The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy

For many years now and based on the results of the PARMA trial, relapsed Diffuse Large B-cell Lymphoma (DLBCL) is treated with salvage combination cytotoxic chemotherapy (most often platinum-based) followed by high dose myeloablative chemotherapy and autologous stem cell transplantation (auto-HCT)....

Descripción completa

Detalles Bibliográficos
Autores principales: Lekakis, Lazaros J., Moskowitz, Craig H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924546/
https://www.ncbi.nlm.nih.gov/pubmed/31976472
http://dx.doi.org/10.1097/HS9.0000000000000295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924546/
https://www.ncbi.nlm.nih.gov/pubmed/31976472
http://dx.doi.org/10.1097/HS9.0000000000000295

Ejemplares similares